Enhua Pharmaceutical Approved Penehyclidine Hydrochloride Injection
Release date: 2020-01-14 Views: 0
On January 14, Jiangsu Enhua Pharmaceutical Co., Ltd. issued an announcement on obtaining the "Drug Registration Approval", stating that its three specifications of the chemical drug penehyclidine hydrochloride injection have been issued by the State Drug Administration Approval.
The announcement shows that penehyclidine hydrochloride injection is a selective anticholinergic drug, which can be used for pre-anesthetic administration to inhibit salivary and airway glands secretion, as well as emergency treatment for organophosphorus poisons (pesticides) poisoning and late poisoning or cholinesterase (ChE ) Maintain atropine after aging. This product has been included in the National Medical Insurance Catalogue (2019 edition) of Class B drugs and the National Essential Medicine Catalogue (2018 edition).
- Basic introduction of Heilongjiang Hexiang Pharmaceutical Co., Ltd.
- How to contact Bermuda Medical (Shanghai) Regenerative Medicine Technology Co., Ltd.
- Shandong Dongfang Huiyi Health Industry Co., Ltd.
- Brief introduction of Zaozhuang Yinhai Pharmaceutical Co., Ltd.
- Contact information of Shandong Dongfang Huiyi Health Industry Co., Ltd.
- Introduction of Bermoudi (Shanghai) Regenerative Medicine Technology Co., Ltd.
- Nature子刊：2020年FDA可能批准的新药 1. Nature issue: FDA may approve new drugs in 2020
- “即用型”CAR-T疗法：权宜之计还是未来的发展方向？ 2. "Ready-to-use" CAR-T therapy: an expedient or future direction?
- 2019年全球新上市的重磅创新药盘点 3. Inventory of blockbuster innovative medicines listed globally in 2019
- 2019年12月全球批准新药概况 4. Global Approval of New Drugs in December 2019
- 18种！ 5. 18 types! National Health Commission issued the first batch of key national high-value medical consumables governance list
- 国家药监局发文为亚硝胺类杂质的控制提供指导 6.SFDA issued a document to provide guidance for the control of nitrosamine impurities
- 福建针对未过一致性评价药品开展带量采购 7.Fujian carries out volume procurement for drugs that have not been consistently evaluated